UNSPSC 51101665: Melarsomine

This classification denotes an antihelminthic agent with the molecular formula C13H21AsN8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 374GJ0S41A, chemically known as bis(2-aminoethyl) p-((4,6-diamino-s-triazin-2-yl)amino)dithiobenzenearsonite but generally known as melarsomine, which bears US NIH Compound Identifier 65962. European Medicines Agency schedules Melarsomine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08719MIG.

UNSPSC 51101665 Melarsomine is a Commodity code that in recent state and local procurement activity covers not melarsomine itself but a broader range of pharmaceutical and medical supply acquisitions, including naloxone, safe drug deactivation systems, generic pharmaceuticals, over-the-counter products, and emergency medical supplies. State and local issuing bodies soliciting under or near this code include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), city fire and rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local facilities across participating jurisdictions including Oregon). The work being solicited ranges from annual consumable purchases for community health initiatives to large-scale generic pharmaceutical contracting across multiple government entities, with procurement vehicles including traditional sealed bid (IFB), Request for Proposal (RFP), and Request for Information (RFI) for market intelligence on emerging models such as direct-to-manufacturer prescription programs.

Recent opportunities span Florida, Texas, Minnesota, and multi-state cooperative arrangements. The City of Tampa Purchasing Department issued IFB 26P00145 for medical and first aid supplies (due March 13, 2026, with an estimated contract value of $700,000) supporting the Tampa Fire Department Rescue Division, with a Small Local Business Enterprise set-aside and 5 percent bid discount. Seminole County, Florida solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through IFB 60459723LAS (due July 26, 2023) with quarterly deliveries to the county community health building. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, requiring vendors to supply through authorized wholesalers with product availability by May 15, 2026 and effective contracts July 1, 2026. The Texas HHS Commission posted RFI HHS0017013 (due April 3, 2026) seeking vendor capability information on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, positioning this as preliminary market research before formal procurement.